Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c13
Identifier NCT07428096
Trial Title A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Fibrostenotic Crohn's Disease
Interventions DRUG: PALI-2108
Participant Information
Sponsor Palisade Bio
City Quebec
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-10-17
Primary Completion Date 2026-01-30
Completion Date 2026-03-15